Literature DB >> 10679036

Clinical and histopathological study of merosin-deficient and merosin-positive congenital muscular dystrophy.

B Talim1, G Kale, H Topaloglu, Z Akçören, M Caglar, S Gögüş, M Elkay.   

Abstract

The clinical features of merosin-positive congenital muscular dystrophy (CMD) and merosin-deficient CMD are well known, with those of merosin-deficient CMD being more severe. Whether the severity of histopathological findings correlates with these clinical features remains unanswered. In this study, the clinical and histopathological findings of 39 merosin-deficient and 37 merosin-positive CMD patients were compared. Merosin-deficient CMD patients were found to be younger, with earlier onset of symptoms, age of diagnosis, and a more severe clinical state (reflecting maximum motor capacity and contractures). On histopathological evaluation, endomysial fibrosis, perimysial fibrosis, and histopathological state (reflecting fibrosis, adiposis, necrosis, and variation in fiber size) were more severe in merosin-deficient CMD. There was a correlation between clinical and histopathological states only in merosin-deficient CMD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679036     DOI: 10.1007/s100240050021

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  2 in total

Review 1.  The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review.

Authors:  K J Jones; G Morgan; H Johnston; V Tobias; R A Ouvrier; I Wilkinson; K N North
Journal:  J Med Genet       Date:  2001-10       Impact factor: 6.318

2.  Nanolipodendrosome-loaded glatiramer acetate and myogenic differentiation 1 as augmentation therapeutic strategy approaches in muscular dystrophy.

Authors:  Ehsan Afzal; Saba Zakeri; Peyman Keyhanvar; Meisam Bagheri; Parvin Mahjoubi; Mahtab Asadian; Nogol Omoomi; Mohammad Dehqanian; Negar Ghalandarlaki; Tahmineh Darvishmohammadi; Fatemeh Farjadian; Mohammad Sadegh Golvajoee; Shadi Afzal; Maryam Ghaffari; Reza Ahangari Cohan; Amin Gravand; Mehdi Shafiee Ardestani
Journal:  Int J Nanomedicine       Date:  2013-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.